论文部分内容阅读
由中国微生物学会病毒学会及中华医学会传染病和寄生虫病学会联合举办的第二次全国干扰素-病毒性肝炎学术会议于1990年10月11～13日在河南省焦作市召开,来自全国16个省市自治区的58名代表出席了会议。会议共收到学术论文55篇,在会议上报告的有34篇。其中4篇专题报告是:1.细胞因子网络的基础和临床研究进展(杜平);2.干扰素治疗乙型慢性肝炎的现状(崔振宇);3.抗病毒药物及抗肝炎病毒疗法研究进展(熊开钧);4.乙型肝炎病毒分子生物学的研究(吴章琦)。我国的乙型肝炎患病率占世界之首,其治疗方法尚未解决,应用干扰素治疗该病已成为国内外医学界关注的问题。从收到的论文看,国内目前应用干扰素治疗慢性乙型肝炎的方法主要有3种:一是
The Second National Interferon-Viral Hepatitis Symposium, co-organized by Society of Virology of Chinese Society of Microbiology and Chinese Society of Infectious Disease and Parasitology, was held in Jiaozuo City, Henan Province from October 11 to October 1990, 58 representatives of 16 provinces, autonomous regions and municipalities attended the meeting. The conference received a total of 55 academic papers, 34 papers reported at the meeting. Among them, 4 thematic reports are: 1. The basic and clinical research progress of cytokine network (Du Ping); 2. The current situation of interferon treatment of chronic hepatitis B (Cui Zhenyu); 3. Advances in antiviral drugs and anti-hepatitis virus therapy (Xiong Kaijun); 4. Hepatitis B virus molecular biology (Wu Zhangqi). The prevalence of hepatitis B in our country occupies the first place in the world, and its treatment has not yet been solved. The application of interferon in the treatment of this disease has become a concern of medical circles at home and abroad. From the received papers, the current application of interferon in the treatment of chronic hepatitis B there are three main ways: First,